| Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis Arch Ophtalmol 129, 545-553, 2011 | 770* | 2011 |
| Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis S Bonini, A Lambiase, P Rama, F Sinigaglia, M Allegretti, W Chao, ... Ophthalmology 125 (9), 1332-1343, 2018 | 243 | 2018 |
| Immunopathology of scleritis LP Fong, MS de la Maza, BA Rice, AE Kupferman, CS Foster Ophthalmology 98 (4), 472-479, 1991 | 191 | 1991 |
| Severity of scleritis and episcleritis MS de la Maza, NS Jabbur, CS Foster Ophthalmology 101 (2), 389-396, 1994 | 175 | 1994 |
| Clinical characteristics of a large cohort of patients with scleritis and episcleritis MS de la Maza, N Molina, LA Gonzalez-Gonzalez, PP Doctor, J Tauber, ... Ophthalmology 119 (1), 43-50, 2012 | 174 | 2012 |
| Systemic chemotherapy for ocular cicatricial pemphigoid J Tauber, MS de la Maza, CS Foster Cornea 10 (3), 185-195, 1991 | 171 | 1991 |
| Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization V Llorenç, M Mesquida, M Sainz de la Maza, J Keller, B Molins, ... Acta Ophthalmologica 93 (6), 561-567, 2015 | 138 | 2015 |
| Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema M Mesquida, B Molins, V Llorenç, MS de la Maza, A Adán Ophthalmology 121 (12), 2380-2386, 2014 | 116 | 2014 |
| The sclera CS Foster, MS de la Maza Springer Science & Business Media, 2013 | 108* | 2013 |
| Scleritis associated with systemic vasculitic diseases MS de la Maza, CS Foster, NS Jabbur Ophthalmology 102 (4), 687-692, 1995 | 105 | 1995 |
| Necrotizing scleritis after ocular surgery: a clinicopathologic study MS de la Maza, CS Foster Ophthalmology 98 (11), 1720-1726, 1991 | 95 | 1991 |
| Scleritis therapy MS de la Maza, N Molina, LA Gonzalez-Gonzalez, PP Doctor, J Tauber, ... Ophthalmology 119 (1), 51-58, 2012 | 83 | 2012 |
| One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease C Baudouin, MS de la Maza, M Amrane, JS Garrigue, D Ismail, ... European Journal of Ophthalmology 27 (6), 678-685, 2017 | 81 | 2017 |
| Twenty-four month follow-up of tocilizumab therapy for refractory uveitis-related macular edema M Mesquida, B Molins, V Llorenç, MV Hernández, G Espinosa, ... Retina 38 (7), 1361-1370, 2018 | 80 | 2018 |
| Certolizumab pegol, a new anti-TNF-α in the armamentarium against ocular inflammation V Llorenç, M Mesquida, M Sainz de la Maza, R Blanco, V Calvo, O Maíz, ... Ocular immunology and inflammation 24 (2), 167-172, 2016 | 79 | 2016 |
| An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis J Tauber, MS de la Maza, T Hoang-Xuan, CS Foster Cornea 9 (1), 66-73, 1990 | 79 | 1990 |
| Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases LA Gonzalez-Gonzalez, N Molina-Prat, P Doctor, J Tauber, ... Ophthalmology 119 (7), 1460-1464, 2012 | 74 | 2012 |
| Sderitis associated with rheumatoid arthritis and with other systemic immunemediated diseases MS de la Maza, CS Foster, NS Jabbur Ophthalmology 101 (7), 1281-1288, 1994 | 74 | 1994 |
| Clinical features and presentation of posterior scleritis: a report of 31 cases LA Gonzalez-Gonzalez, N Molina-Prat, P Doctor, J Tauber, ... Ocular Immunology and Inflammation 22 (3), 203-207, 2014 | 72 | 2014 |
| Phase I trial of recombinant human nerve growth factor for neurotrophic keratitis S Bonini, A Lambiase, P Rama, I Filatori, M Allegretti, W Chao, F Mantelli, ... Ophthalmology 125 (9), 1468-1471, 2018 | 69 | 2018 |
